Medline Inc. (MDLN) vs Waters Corporation (WAT)

A side-by-side comparison of Medline Inc. and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnMDLN vs WAT

growth of $100 · dividends reinvested · last 1y
MDLN -10.6%WAT +1.0%WAT compounded faster
708090100110120Start $1002026$89$101
MDLN WAT

MDLN vs WAT: by the numbers

  • WAT is the larger company ($29.74B vs $29.16B market cap).
  • MDLN trades at the lower trailing earnings multiple (30.31 vs 99.68 P/E), one valuation lens rather than an overall verdict.
  • WAT converts more revenue to profit (3.58% vs 3.31% net margin).

Metrics side by side

Valuation

MetricMDLNWAT
P/E ratio30.3199.68
Forward P/E24.2127.53
P/S ratio1.048.45
P/B ratio2.682.58
PEG ratioN/A75.61
EV / EBITDA13.6347.20
FCF yield5.04%1.01%

Profitability

MetricMDLNWAT
Gross margin24.04%50.78%
Operating margin7.04%28.22%
Net margin3.31%3.58%
ROE8.55%1.09%
ROIC5.69%17.57%

Growth (annualized)

MetricMDLNWAT
Revenue CAGR (5Y)N/A11.70%
EPS CAGR (5Y)N/A5.16%
FCF CAGR (5Y)N/A-9.19%
Total return CAGR (5Y)N/A0.21%

Frequently asked

Which has the lower trailing P/E, MDLN or WAT?
MDLN has the lower trailing P/E: MDLN trades at 30.31 and WAT at 99.68. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is MDLN or WAT more profitable?
WAT runs the higher net margin — MDLN at 3.31% versus WAT at 3.58%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 6, 2026.